retatrutide withdrawal The numbers from Lilly's Phase 3 trial dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user Retatrutide Dosage & Dosing Guide:

An NPR report from February 2026 explored the benefits and risks of using GLP-1 medications at a normal BMI, noting that the long-term effects of these drugs in normal-weight populations are not well studied

Understanding support scope helps researchers determine whether they need self-sufficiency or can rely on vendor assistance for protocol questions

The treatment also showed a manageable safety profile, supporting its potential as a less-frequent dosing alternative to current GLP-1-based therapies

The Bottom Line Ro is a suitable option for patients seeking brand-name tirzepatide

M., Guiguer, E

The weight loss medication market continues to expand rapidly as research evolves